The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $9.54

Today's change+0.84 +9.66%
Updated March 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $9.54

Today's change+0.84 +9.66%
Updated March 24 4:02 PM EDT. Delayed by at least 15 minutes.

Community Health Systems Inc crosses above 200-day moving average

Community Health Systems Inc closed up sharply Friday, rallying (U.S.)$0.84 or 9.66% to (U.S.)$9.54 and crossing above its 200-day moving average. Over the last five days, shares have gained 2.14% and 70.66% year to date. Shares have underperformed the S&P 500 by 59.47% during the last year.

Key company metrics

  • Open(U.S.) $8.78
  • Previous close(U.S.) $8.70
  • High(U.S.) $9.65
  • Low(U.S.) $8.78
  • Bid / Ask-- / --
  • YTD % change+70.66%
  • Volume6,789,796
  • Average volume (10-day)3,872,807
  • Average volume (1-month)4,861,756
  • Average volume (3-month)3,891,659
  • 52-week range(U.S.) $4.15 to (U.S.) $21.38
  • Beta1.75
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.00×
  • Forward PEG39.03×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$15.39
Updated March 24 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-8.74%

Although this company's net profit margin is negative, it is above the industry average and implies that Community Health Systems Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue4,4694,3804,5904,999
Total other revenue--------
Total revenue4,4694,3804,5904,999
Gross profit3,7393,6573,8314,200
Total cost of revenue730723759799
Total operating expense4,3944,2345,9954,705
Selling / general / administrative2,1972,1762,2662,436
Research & development--------
Depreciation / amortization261265276298
Interest expense (income), net operating--------
Unusual expense (income)230491,66917
Other operating expenses, total9761,0211,0251,155
Operating income75146-1,405294
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-152-83-1,54363
Income after tax-189-54-1,40537
Income tax, total37-29-13826
Net income-221-79-1,43211
Total adjustments to net income--------
Net income before extra. items-211-77-1,43112
Minority interest-22-23-26-25
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-211-77-1,43112
Inc. avail. to common incl. extra. items-221-79-1,43211
Diluted net income-221-79-1,43211
Dilution adjustment00--0
Diluted weighted average shares111111111110
Diluted EPS excluding extraordinary itemsvalue per share-1.90-0.69-12.910.11
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.55-0.41-3.120.20